Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial

379

Citations

17

References

2019

Year

Robert Croop, Peter J. Goadsby, David Stock, Charles M. Conway, Micaela Forshaw, Elyse Stock, Vladimir Coric, Richard B. Lipton

Acute TreatmentCluster HeadacheMedicinePlacebo-controlled TrialPharmacotherapyNeurologyPharmacologyPhase 3

References

	Year	Citations

Page 1